Petros Grivas, Begoña P. Valderrama, Marinos Tsiatas, Peter Mu-Hsin Chang, Miso Kim, Lorenzo Antonuzzo, Sang Joon Shin, Georgios Gakis, Normand Blais, Se Hyun Kim, José Ángel Arranz Arija, Harvey Yu-Li Su, Flora Zagouri, Marco Maruzzo, Astrid Schneider, Karin Tyroller, Jason Hoffman, Natalia Jacob, Jeannie Hoffman-Censits. "Avelumab + sacituzumab govitecan (Ave + SG) vs avelumab monotherapy (Ave mono) as first-line (1L) maintenance treatment for advanced urothelial carcinoma (aUC): Updated subgroup analyses of JAVELIN Bladder Medley based on metastatic sites.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.4568